In GBM cells, the treatment of caffeine reduces cell proliferation by modulating MAPK signaling and expression of the proteolytic enzymes [212] while invasion by blocking IP3R3-mediated Ca2+ release [213] and HIFs/VEGF pathways [214]. The gene discussed is VEGFA; the disease is glioblastoma.